Brief: Mesoblast Updates On Option To Issue Up To $50M Convertible Notes

Mesoblast

30/09/2024 03:47

Sept 30 (Reuters) - Mesoblast Ltd  MSB.AX :
    * MESOBLAST OPTION TO ISSUE UP TO US$50M CONVERTIBLE NOTES
    * TO ISSUE CONVERTIBLE NOTES IN TRANCHES OF US$10 MILLION AT
ANY
TIME FOLLOWING AN FDA APPROVAL OF RYONCIL FOR A 90-DAY PERIOD


Further company coverage:  MSB.AX 

 ((Reuters.Briefs@thomsonreuters.com;))